NOTE: This Emergency Use Authorization (EUA) is being issued in response to the need for in vitro diagnostic devices to detect antibodies to SARS-CoV-2 during the Coronavirus Disease 2019 (COVID-19) pandemic. Highly stable and uniform nanoparticles. The quality and performance of a conjugate is critical to successful lateral flow test manufacturing. Our products are produced in a state-of-the-art manufacturing facility that enable rapid turnaround times while ensuring batch to batch consistency and reliability. This test has not been reviewed by the FDA.
- UPC:
- 12350000
- Condition:
- New
- Availability:
- 3 Days
- Weight:
- 1.00 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- AU2019-25
